Human Umbilical Cord Mesenchymal Stem Cells for Adjuvant Treatment of a Critically Ill COVID-19 Patient: A Case Report
| Autor: | Dayong Xu, Robert Chunhua Zhao, Li Li, Kun Liu, Dunyao Bai, Yan Liu, Yan Zhang, Yue Zhu, Dezhong Chen, Yixun Liu, Xin Li, Jieli Luo, Rongjia Zhu, Junfang Hu |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Pharmacology medicine.medical_specialty Coronavirus disease 2019 (COVID-19) business.industry Critically ill Public health medicine.medical_treatment 030106 microbiology Treatment process Mesenchymal stem cell Case presentation Umbilical cord 03 medical and health sciences 0302 clinical medicine Infectious Diseases medicine.anatomical_structure Medicine Pharmacology (medical) 030212 general & internal medicine business Intensive care medicine Adjuvant |
| Zdroj: | Infection and Drug Resistance. 13:3295-3300 |
| ISSN: | 1178-6973 |
| Popis: | Background: COVID-19 (coronavirus disease 2019) has become a global public health emergency since patients were first detected in Wuhan, China, in December 2019 Currently, there are no satisfying antiviral medications and vaccines available Case Presentation: We reported the treatment process and clinical outcome of a 48-year-old man critically ill COVID-19 patient who received transfusion of allogenic human umbilical cord mesenchymal stem cells (UC-MSCs) Conclusions: We proposed that UC-MSC transfusion might be a new option for critically ill COVID-19 Although only one case we were shown, more similar clinical cases are inquired for further evidence providing the potential effectiveness of UC-MSC treatment © 2020 Zhu et al |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|